Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.47
1.44%
After-hours: Aug 15, 2025, 07:52 PM EDT
Cardiff Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 425K | 588K | 684K | 689K | 665K | 610K | 488K | 460K | 412K | 395K | 386K | 391K | 384K | 361K | 359K | 345.25K | 395.66K | 370.29K |
Cost of Revenue | 96K | 201K | 303K | 310K | 417K | 410K | 398K | 345K | 319K | 259K | 200K | 312K | 4.38M | 8.47M | 11.71M | 14.75M | 13.45M | 11.81M |
Gross Profit | 329K | 387K | 381K | 379K | 248K | 200K | 90K | 115K | 93K | 136K | 186K | 79K | -4M | -8.11M | -11.36M | -14.41M | -13.06M | -11.44M |
Operating Income | -54.33M | -52.1M | -48.65M | -46.41M | -44.63M | -44.29M | -45.41M | -44.47M | -42.65M | -40.88M | -39.9M | -40.04M | -38.04M | -34.49M | -28.86M | -25.83M | -23.19M | -20.4M |
Interest Income | 2.47M | 3.27M | 3.26M | 3.48M | 3.81M | 4.05M | 4.07M | 3.8M | 3.19M | 2.39M | 1.58M | 977K | 589K | 407K | 334K | 220.45K | 166.31K | 111.31K |
Pretax Income | -51.03M | -48.86M | -45.44M | -42.99M | -40.86M | -40.23M | -41.44M | -40.8M | -39.64M | -38.93M | -38.7M | -39.45M | -37.79M | -34.1M | -28.29M | -25.45M | -23.03M | -20.4M |
Net Income | -51.02M | -48.85M | -45.43M | -42.98M | -40.86M | -40.23M | -40.61M | -39.28M | -37.7M | -36.73M | -37.25M | -38.69M | -37.46M | -34.02M | -28.29M | -25.45M | -23.03M | -20.4M |
Selling & General & Admin | 13.47M | 13.37M | 12.38M | 12.09M | 11.91M | 12.99M | 13.04M | 13.4M | 13.53M | 12.32M | 13.18M | 13.94M | 13.79M | 13.54M | 11.84M | 11.42M | 10.13M | 8.97M |
Research & Development | 41.41M | 39.32M | 36.85M | 34.9M | 33.29M | 31.81M | 32.86M | 31.54M | 29.52M | 28.95M | 27.11M | 26.49M | 24.63M | 21.3M | 17.38M | 14.75M | 13.45M | 11.81M |
Other Expenses | n/a | -38K | -42K | -55K | -34K | 9K | -98K | -130K | -187K | -192K | -130K | -85K | -46K | -46K | 2K | -24.28K | -33.02K | -26.76K |
Operating Expenses | 54.88M | 52.58M | 49.13M | 46.79M | 44.98M | 44.7M | 45.8M | 44.93M | 43.06M | 41.27M | 40.29M | 40.43M | 38.42M | 34.85M | 29.21M | 26.17M | 23.59M | 20.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 79K | 79K | 79K | 79K | 1.52K | 17.38K | 17.38K |
Selling & Marketing Expenses | -357K | 102K | n/a | -956K | -820K | -695K | -593K | 1.12M | 584K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.98M | 52.69M | 49.34M | 47.1M | 45.3M | 44.9M | 45.9M | 44.93M | 43.06M | 41.27M | 40.29M | 40.43M | 38.42M | 34.85M | 29.21M | 26.17M | 23.59M | 20.77M |
Income Tax Expense | n/a | n/a | 58.72K | 58.72K | 58.72K | 58.72K | -829K | -1.52M | -1.95M | -2.2M | -1.45M | -677K | -255K | -2K | 79K | n/a | 128.17K | 156.64K |
Shares Outstanding (Basic) | 66.53M | 66.52M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.59M | 39.55M | 38.76M | 37.16M |
Shares Outstanding (Diluted) | 66.53M | 47.65M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.6M | 39.55M | 38.76M | 37.16M |
EPS (Basic) | -0.91 | -0.96 | -0.98 | -0.94 | -0.91 | -0.9 | -0.91 | -0.88 | -0.85 | -0.84 | -0.86 | -0.91 | -0.89 | -0.82 | -0.71 | -0.76 | -0.78 | -0.89 |
EPS (Diluted) | -0.99 | -1.04 | -0.98 | -0.94 | -0.91 | -0.9 | -0.91 | -0.88 | -0.85 | -0.84 | -0.86 | -0.91 | -0.89 | -0.82 | -0.71 | -0.76 | -0.78 | -0.89 |
EBITDA | -53.91M | -51.57M | -48.25M | -46M | -44.21M | -43.88M | -45.01M | -44.09M | -42.29M | -40.59M | -39.67M | -39.64M | -37.62M | -33.99M | -28.27M | -25.47M | -22.83M | -20.04M |
EBIT | -39.55M | -52.1M | -48.65M | -46.41M | -44.63M | -44.29M | -45.41M | -44.47M | -42.65M | -40.88M | -39.9M | -39.47M | -37.48M | -33.92M | -28.29M | -26.05M | -23.41M | -20.62M |
Depreciation & Amortization | 425K | 530K | 404K | 411K | 417K | 410K | 398K | 345K | 319K | 259K | 200K | 312K | 341K | 412K | 500K | 455.26K | 460.26K | 466.26K |